Recommended Pages at hemonctoday.com

Physicians with healthy habits likely to urge lifestyle changes to patients | HemOncToday

hemonctoday.com — “Physicians who practice healthy habits are likely to recommend important lifestyle modifications to their patients, results of a survey suggest.View full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 12:44 pm By:

HemOncToday HemOnc Today Oncology and Health News

Physicians with healthy habits likely to urge lifestyle changes to patients: http://t.co/wukIi0ny

2 months ago...

ODAC rejects ridaforolimus as maintenance therapy for sarcoma | HemOncToday

hemonctoday.com — “An FDA panel rejected ridaforolimus as a maintenance therapy for patients with soft-tissue or bone View full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 5:10 pm By:

HemOncToday HemOnc Today Oncology and Health News

ODAC rejects ridaforolimus as maintenance therapy for sarcoma: http://t.co/wgR3AMi1

2 months ago...

ODAC supports approval of sarcoma drug | HemOncToday

hemonctoday.com — “An FDA panel overwhelmingly expressed its support for the approval of pazopanib for patients with advanced soft tissue View full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 7:59 pm By:

Diesel exhaust exposure linked to increased risk for lung cancer mortality | HemOncToday

hemonctoday.com — “Diesel exhaust exposure linked to increased risk for lung cancer mortality | HemOncTodayView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 11:45 am By:

HemOncToday HemOnc Today Oncology and Health News

Diesel exhaust exposure linked to increased risk for lung cancer mortality: http://t.co/PZbII5oS

2 months ago...

AAP now recommends HPV vaccine for boys and girls | HemOncToday

hemonctoday.com — “The American Academy of Pediatrics Committee on Infectious Diseases issued an updated policy statement on human papillomavirus vaccination thatView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 19, 2012 at 12:04 pm By:

HemOncToday HemOnc Today Oncology and Health News

The American Academy of Pediatrics Committee on Infectious Diseases recommends HPV vaccine for both boys and girls: http://t.co/QsBQaO48

2 months ago...

Discovering the rewards of joining Twitter’s clinical medicine conversation | HemOncToday

hemonctoday.com — “As an oncology fellow, I had some interesting conversations with friends and colleagues about the use of patient–physician email in clinView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 16, 2012 at 10:15 pm By:

rsm2800 Robert S. Miller, MD Oncologist, Physician, Doctor, and Internist

Discovering the rewards of joining Twitter’s clinical medicine conversation http://t.co/Zkr2z4Cr via @WoodBD -->grt to have you involved!

2 months ago...

Semuloparin linked to reduced thromboembolic events in patients receiving chemotherapy | HemOncToday

hemonctoday.com — “Patients receiving chemotherapy who were treated with semuloparin were more than 60% less likely to experience venous thromboembolism than patieView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 10:00 pm By:

HemOncToday HemOnc Today Oncology and Health News

Semuloparin linked to reduced thromboembolic events in patients receiving chemotherapy: http://t.co/91nq1RYe

2 months ago...

Increased mammography screening linked to reduced treatment, recurrence in women aged 40 to 49 years | HemOncToday

hemonctoday.com — “Increased mammography-detected breast cancer was associated with lower-stage disease detection resulting in reduced treatment and lower rates ofView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 7:46 pm By:

HemOncToday HemOnc Today Oncology and Health News

Increased mammography screening linked to reduced treatment, recurrence in women aged 40 to 49 years: http://t.co/JqvOlIZg

3 months ago...

ODAC rejects expanded use for bone drug in men with prostate cancer | HemOncToday

hemonctoday.com — “The FDA’s Oncologic Drugs Advisory Committee rejected a request from Amgen to allow denosumab to be used as a preventive measure for men wView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on February 9, 2012 at 1:11 pm By:

HemOncToday HemOnc Today Oncology and Health News

ODAC rejects expanded use for bone drug in men with prostate cancer: http://t.co/eFDclp28

4 months ago...

FDA grants priority review for HER-2—positive breast cancer treatment | HemOncToday

hemonctoday.com — “FDA grants priority review for HER-2—positive breast cancer treatment | HemOncTodayView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on February 7, 2012 at 8:19 pm By:

HemOncToday HemOnc Today Oncology and Health News

FDA grants priority review for HER-2—positive breast cancer treatment: http://t.co/rr655isL

4 months ago...

Packed red blood cells increased infection risk after cardiac surgery | HemOncToday

hemonctoday.com — “Patients with packed red blood cells had an increased risk for major infection after cardiac surgery, according to study results presented atView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on February 3, 2012 at 3:58 pm By:

HemOncToday HemOnc Today Oncology and Health News

“...reducing packed red blood cell transfusions may significantly reduce incidence of major post-operative infections” http://t.co/NER4XlT0

4 months ago...

FDA approves imatinib mesylate tablets for GIST | HemOncToday

hemonctoday.com — “The FDA today approved imatinib mesylate tablets for the adjuvant treatment of adult patients after complete gross resection of CD117-positive gView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on February 1, 2012 at 3:58 pm By:

HemOncToday HemOnc Today Oncology and Health News

FDA approves imatinib mesylate tablets for GIST: http://t.co/T6fr3gKa

4 months ago...

Monoclonal antibody detected early-stage pancreatic cancer marker | HemOncToday

hemonctoday.com — “Monoclonal antibody detected early-stage pancreatic cancer marker | HemOncTodayView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on January 31, 2012 at 1:02 pm By:

HemOncToday HemOnc Today Oncology and Health News

"The study shows tremendous promise that the serum can add significantly to our ability to diagnose pancreatic cancer" http://t.co/QJs1gp00

4 months ago...

FDA approves first drug for metastatic basal cell carcinoma | HemOncToday

hemonctoday.com — “FDA approves first drug for metastatic basal cell carcinoma | HemOncTodayView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on January 30, 2012 at 9:07 pm By:

HemOncToday HemOnc Today Oncology and Health News

FDA approves vismodegib for the treatment of adults with basal cell carcinoma: http://t.co/Yl35XCgo

4 months ago...

NO16968: Xelox improved 7-year OS in advanced colon cancer | HemOncToday

hemonctoday.com — “NO16968: Xelox improved 7-year OS in advanced colon cancer | HemOncTodayView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on January 23, 2012 at 8:16 pm By:

HemOncToday HemOnc Today Oncology and Health News

"The death rate due to colon cancer was 26% for 5-FU/leucovorin and 20% for Xelox...” http://t.co/h7nqx8XW

4 months ago...

 1 2 3 4 Next ›  Last »